Fujifilm Corp. said it has established an offshoot of Fujifilm Life Science in Korea to grow and accelerate the cell culture medium business on Oct. 4.Fujifilm plans to supply high-quality cell culture media for bioproduction and cell- and gene-based advanced therapeutics through Fujifilm Life Scien
Clupea, a medical big data platform company, said on Tuesday that it will jointly establish the first non-clinical big data platform based on Clinical Data Interchange Standards Consortium (CDISC) standards with the Korea Institute of Toxicology (KIT).Clupea's Medilake platform technology, which is
Aprogen has reversed its plan to acquire a cGMP plant in the United States less than a day after the initial announcement, causing repercussions.“We are examining various strategies, including the acquisition of a U.S. plant approved by the FDA, to respond to the U.S. government’s ‘made-in-America'
Severance Hospital said on Friday that its researchers have developed a mesenchymal stem cell (MSC)/anticancer virus complex carrier that improves the ability to quickly and accurately target cancer cells 100 times better than conventional carriers.The oncolytic virus penetrates into cancer cells, p
Samsung Biologics is drawing the industry’s attention by preemptively launching a CDMO (contract development and manufacturing organization) business targeting the growing market of bispecific antibody medical products.The company said Thursday that it has released “S-DUAL,” an independently develop
A team of researchers at Gangnam Severance Hospital said they discovered a pathological complete response (pCR) when administering HER2 positive breast cancer patients with a dose of carboplatin together with neoadjuvant TCHP (Taxotere +Carboplatin+Herceptin+Perjeta).HER2 benign breast cancer exhibi
Celltrion’s ambitious intestinal disease management app, named “Manager Care,” has been confirmed to suffer from sluggish download numbers four months after its launch, according to market watchers.On Tuesday, Celltrion said it would launch the intestinal disease management service app Manager Care
Korean companies are rapidly joining the race to develop microbiome-based live biotherapeutic products (LBPs).Industry officials and academics recently gathered in Seoul to discuss how to boost technological strengths and continue research and development in this promising market.At COEX on Thursday
GC Genome said Thursday that it has launched the “Hair Loss Risk Screen” test, which can check the risk of genetic development by hair loss type by selecting genes related to hair loss.The company’s latest product identifies genetic factors that may affect male and female alopecia and alopecia areat
TiumBio said on Tuesday that it received a $4.5 million upfront payment from China’s Hansoh Pharmaceutical under the previous licensing agreement involving TU2670, a new endometriosis treatment.Earlier in August, TiumBio and Hansoh signed a $170 million deal, including a $4.5 million upfront payment
Mirae Asset Venture Investment and Yuanta Investment have been selected as the management companies of the 500 billion won ($347 million) “K-Bio Vaccine Fund.”The Ministry of Health and Welfare and Korea Venture Investment Corp. (KVIC) on Wednesday announced their final selection of Mirae Asset Vent
Samsung Bioepis said Tuesday that it would present three scientific abstracts for its ophthalmology biosimilars at the American Academy of Ophthalmology (AAO) 2022 from Sept. 30 to Oct. 3 in the U.S.The company conducted phase 3 studies to compare the efficacy, safety, immunogenicity, and pharmacoki
Researchers from Seoul National University College of Medicine (SNUCM) found that frequently consuming small amounts of alcohol increased the risk of developing gastric cancer.The study, led by Professor Kang Dae-hee, investigated 128,218 healthy middle-aged Korean adults aged 40 to 69 who participa
Celltrion said Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Vegzelma, a biosimilar referencing Avastin (ingredient: bevacizumab) to treat various cancers.The approval in Japan follows Celltrion obtaining marketing approval for Vegzelma from the European Commission (EC) in Augus
The International Vaccine Institute (IVI) is hosting its 21st international five-day vaccinology course at the SNU Faculty House Convention Center which will run through Friday this week.IVI's Director General, Dr. Jerome Kim, said the trainees had to focus on moving vaccines from “need” to “impact”
A team of researchers at Seoul National University Bundang Hospital said they discovered that a thinner retinal nerve fiber layer (RNFL) was associated with a higher risk of cognitive impairment in a large cohort study.It is the first time in Korea that a local study identified the relationship betw
Researchers of the Urology Department at Asan Medical Center (AMC) said they have discovered a way to improve symptoms caused by interstitial cystitis or bladder pain syndrome by administering mesenchymal stem cells derived from human embryonic stem cells.Interstitial cystitis, which is accompanied
A Pakistani professor from a Swiss university said consanguineous marriages were the best resource to study recessive disorders because it is easier to identify new genes in this population.Muhammad Ansar from the University of Lausanne presented on the discovery of new recessive disease genes and t
A team of researchers at Yonsei Severance Hospital said they discovered six key cardiovascular health (CVH) metrics to reduce dementia risk in a recent study.According to the World Health Organization (WHO), dementia is the deterioration in cognitive function which affects memory, thinking, orientat
A joint research team from Korea Advanced Institute of Science and Technology (KAIST) said on Wednesday they developed a bio-friendly adhesive by mixing tannic acid with bio-compatible polymers to improve existing hair transplant methods.Tannic acid is a type of polyphenol found in fruit shells, nut